The effect of surfactants modification on nanocrystalline cellulose for paclitaxel loading and release study
-
Add time:09/24/2019 Source:sciencedirect.com
The Nanocrystalline cellulose (NCC) was prepared from filter paper by acid hydrolysis process. The modification of NCC with cationic, anionic, and nonionic surfactant did not have a tremendous effect on the chemical structure of material based on the characterization of XRD and FTIR. The modified NCCs were employed as a drug carrier for paclitaxel (PTX). Increasing concentration of ionic surfactants can enhance the loading of the hydrophobic drug, while the opposite trend was observed for nonionic surfactant modified nanocrystals. The attachment of surfactant toward the particle was a more likely physical aggregation of micelle on the surface of nanocrystals. Larger particle size was observed after the modification of nanocrystal cellulose. The fitting of Higuchi and sigmoidal models were applied in the release profile to investigate the kinetic release mechanism of paclitaxel at pH 5.8 and 7.4. Cell viability was determined to check the biocompatibility of the materials toward mouse osteoblast cells 7F2 using MTT assay. Toxic behavior was not observed for NCC, while CTAB was completely not compatible with cells.
We also recommend Trading Suppliers and Manufacturers of PACLITAXEL SIDE CHAIN NO 1 (cas 133066-61-2). Pls Click Website Link as below: cas 133066-61-2 suppliers
Prev:Original ArticleCycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
Next:A novel non-enzymatic sensing platform for determination of 5′-guanosine monophosphate in meat) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Original ArticleCycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells09/10/2019
- Synthesis, isolation, stereostructure and cytotoxicity of paclitaxel analogs from cephalomannine09/09/2019
- Historical PerspectiveBasic principles of drug delivery systems – the case of paclitaxel09/08/2019
- Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro09/07/2019
- Topical PerspectivesToward an ab initio potential energy surface for paclitaxel: A C-13 isoserine side chain conformational study09/06/2019
- Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates09/05/2019
- Design, synthesis and biological evaluation of paclitaxel-mimics possessing only the oxetane D-ring and side chain structures09/04/2019
- A convenient one-pot approach to Paclitaxel (Taxol) side chain via 1,3-dipolar cycloaddition of carbonyl ylides and N-benzoylbenzyl imines09/03/2019
-
Health and Chemical more >


